



Nowadays the association 
between gestational parvovi-
rus B19 infection and fetal 
loss has increased interest in 
this virus and demand for 
additional desirably nonin-
vasive diagnostic procedures. 
This human pathogenic vi-
rus associated with a wide 
range of clinical conditions, 
may affect many fetal organs 
and can cause fetal morbidi-
ty and mortality with severe 
anemia, following fetal eryth-
roid progenitor cells infection 
and apoptosis. Severe anemia 
may cause high output car-
diac failure and nonimmune 
fetal hydrops. In addition, 
parvovirus B19 may directly 
infect myocardial cells and 
produce myocarditis that fur-
ther aggravates the cardiac 
failure [1, 2]. So, improvement 
of new practical and reliable 
methods for identification fe-
tal abnormalities are becom-
ing more important in the 
modern obstetrics.
Maternal serum alpha-fe-
toprotein testing is common-
ly used during the second tri-
mester to screen for various 
fetal genetic defects (neural 
tube defects, chromosomal 
abnormalities). However, its 
role in anemia and erythro-
poiesis is less recognized. Lev-
els of this biochemical marker 
can be elevated in women in-
fected by parvovirus B19 and 
probably come of from dam-
age fetal liver cells or infected 
placental cells [3], but there is 
still no clear data on this fact, 
which is particularly relevant. 
Maternal alpha-fetoprotein is 
correlated with both Doppler 
blood flow velocity param-
eters in the middle cerebral 
artery and fetal hemoglobin. 
Elevations of this marker may 
appear earlier than Doppler 
abnormalities in cases of fetal 
anemia associated with hy-
drops [3]. 
Also routine histological 
studies can play an import-
ant role in the diagnosis of 
B19 infection and provide 
a strong presumptive evi-
dence of intrauterine fetal 
injure. 
The susceptibility of pla-
cental cells – cytotrophoblast 
and syncytiotrophoblast to 
parvovirus B19 infection and 
its cytotoxic effect on target 
cells determine the nature 
of the pathogenic disorders, 
including spontaneous mis-
carriages, stillbirth and fetal 
death before full 21 gesta-
tion weeks. Numerous clini-
cal studies quite clearly show 
that the most of women who 
were infected with parvovi-
rus during pregnancy gave 
birth to healthy children [4]. 
According to the literature 
data, the most negative effect 
for the fetus and risk of intra-
uterine fetal death is the larg-
est when the parvovirus B19 
infection appeared before 
20 weeks of pregnancy. The- 
se terms are corresponding 
to the development and for-
mation of the placenta – crit-
ical period of placentation. 
Transmission of virus may 
occur not only through dam-
age in the protective placen-
tal barrier, but also through 
endocytosis or receptor-me-
diated transfer. The mech-
anism by which the virus 
can be transmitted from the 
infected mother to the fetus 
was studied using experi-
mental models which found 
that immunoreactivity for 
B19 infection was most pro-
nounced in the sponged tro-
phoblastic placental cells in 
the first trimester; reduction 
in reactivity was observed in 
the placenta cells in the sec-
ond trimester, but almost no 
coloration of the antigen was 
noted in the third trimester 
[5]. The reason for this dif-
ference for fetal effects is not 
only the presence of a greater 
number of target cells during 
the first and second trimes-
ter, but also a greater num-
ber of viral receptors on the 
spider trophoblast layer of 
the placenta. Infection with 
pregnant parvovirus B19 is 
usually diagnosed using the 
immune enzyme method to 
detect IgM antibodies to par-
vovirus [6]. According to sta-
tistical data, vertical trans-
mission of parvovirus to the 
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Abstract: Aim of the work. The focus of this study was to analyze the 
frequency of fetal intrauterine symptomatic realization as a result of 
B19 parvovirus infection of pregnant women during I and II gestation 
periods, with the combination of determination the levels of alpha-fe-
toprotein in maternal serum blood and histopathological investigation 
of placenta in cases of negative effects for infected fetuses.
Materials and methods. A total of 478 pregnant women were at risk 
of infection and screened for parvovirus B19. The study was based 
on serological, morphological and virological testing of fetuses from 
mothers with confirmed parvovirus B19 infection. Infection of preg-
nant women was detected by serological diagnosis of specific anti-
bodies IgM and IgG to parvovirus B19. Intrauterine fetal infection 
was confirmed by polymerase chain reaction method. Levels of al-
pha-fetoprotein in meternal venous blood were detected using an im-
munochemical test method. An antenatal diagnosis of hydrops fetalis 
was confirmed by ultrasound scanning. Placenta from the 8 infected 
fetuses was studied histologically with hematoxylin and eosin staining 
using electron microscope during gestational periods of 12–22 weeks. 
Statistical analysis of the obtained data was carried out using nonpar-
ametric statistics with the definition of Fisher's criterion.
Results and discussion. The average gestational period of symptomat-
ic manifestations of intrauterine fetal infection was 19.9±0.5 weeks of 
gestation. It was established that in 33 of cases were confirmed the in-
trauterine infection due to parvovirus B19 by using the morphological 
placenta tissue analysis. The research found that the levels of maternal 
serum alpha-fetoprotein was significantly higher (in 2.17 times) in 
group of fetuses who suffered from fetal hydrops and in cases of intrau-
terine fetal death before detecting the general echographic sings of fetal 
failure (p˂0.05). It will be very important to compare this indicator with 
the Doppler ultrasound measurements of the human fetal middle cer-
ebral artery peak systolic velocity (MCA PSV) and blood flow param-
eters in the fetal ductus venosus and to predict the possibility of poor 
perinatal outcomes. It was identified a cytopathic effect in placental cells 
viral origin and detected in cells of the cytotrophoblast, syncytiotropho-
blast, endothelial cells, and blood cells.
Conclusions. Parvovirus B19 fractions were visualized in 100 % of cas-
es of miscarriages with fetal hydrops and placental edema during 12– 
22 weeks of gestation, while acute maternal parvovirus infection (with the 
detection of IgM against to parvovirus B19) was diagnosed by immuno-
assay only in 62.5 % of cases. 
Detection of B19 particles in placental tissue from fetuses with non-im-
mune origin hydrops is an auxiliary method in the diagnosis of vertical 
transmission of parvovirus during pregnancy.
It is more preferable to estimate the levels of alpha-fetoprotein in ma-
ternal serum blood in case of parvovirus B19 affected pregnancies as 
raising rates of this marker may be an early prediction hallmark for 
adverse fetal outcome.
Keywords: histopathology, parvovirus B19 infection, B19 virions, non-im-
mune fetal hydrops, fetal death, spontaneous miscarriage, cytotropho-
blast, syncytiotrophoblast, pregnancy, intrauterine symptomathy.
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fetus occurs in 56 % of cases. However, fetal hydrops may occur, 
as in the symptomatic and asymptomatic clinical maternal 
forms of parvovirus infection [7, 8]. In serum specific antibod-
ies to B19 can disappear within 3–4–5 weeks from the onset of 
acute infection [9]. In such cases, high levels of IgG to parvovi-
rus may indicate a history of a mother’s infection. Thus, testing 
for parvovirus-specific IgM before childbirth or miscarriage 
may be ineffective in terms of diagnosing intrauterine infec-
tion [10]. More informative diagnostic hallmark for parvovirus 
infection is the detection viral DNA fraction in the mother’s se-
rum blood [11] by means of a nested polymerase chain reaction 
of dot-blot hybridization and hybridization in situ. 
Aim of the research was to analyze the frequency of fetal in-
trauterine symptomatic realization as a result of B19 parvovirus 
infection of pregnant women during I and II gestation periods, 
with the combination of determination the levels of alpha-feto-
protein in maternal serum blood and histopathological investi-
gation of placenta in cases of negative effects for infected fetuses.
2. Methods
The study was conducted during the period from January 
2011 to May 2018 and based on serological, morphological and 
virological testing of fetuses from mothers with confirmed 
parvovirus B19 infection. Infection of pregnant women was 
detected by serological diagnosis of specific antibodies IgM and 
IgG to parvovirus B19. 
Intrauterine fetal infection was confirmed by polymerase 
chain reaction (PCR) reagents with hybridization detection 
«AmpliSens» (Russia) and the immune enzyme immunoassay 
method, the test system EUROIMMUN (Germany).
Levels of alpha-fetoprotein in maternal venous blood were 
detected using an immunochemical test method with electro-
chemiluminescence immunoassay (ECLIA) on Cobas 6000 (e 
601 module), test system Roche Diagnostics (Switzerland).
An antenatal diagnosis of hydrops fetalis was confirmed by 
ultrasound scanning. 
Placenta from the 8 infected fetuses was studied histo-
logically with hematoxylin and eosin staining according to 
standard procedures during gestational periods of 12-22 weeks. 
The material was fixed in 2.5 % glutaraldehyde solution on 
phosphate buffer with fixation with 1 % solution of osmium 
tetroxide. The material dehydrated in alcohols with increasing 
concentration (70 %, 80 %, 90 %, 100 %) and with the help of 
acetone. After block polymerization methods we used ultra-
microtomes LKB III (Sweden) and Reihart (Austria), ultrathin 
sections of 40 nm were made which were contrasted with a 2 % 
solution of uranyl acetate and lead citrate. The microslides were 
studied and photographed under an electron microscope of 
PEM-125K with an increase of 9.6–20 thousand times. Viruses 
were studied in microphotographs with an increase of 40–60 
thousand. Statistical analysis of the obtained data was carried 
out using nonparametric statistics with the definition of Fisher’s 
criterion.
3. Results
A total of 478 pregnant women were at risk of infection 
and screened for parvovirus B19. During serological and viro-
logical testing, it was found that 32 % of women had already 
immunized against parvovirus B19, that is, they have had in 
the past B19. In the serum of these pregnant women, only 
specific IgG antibodies to parvovirus B19 were determined. 41 
% of pregnant women had negative results of laboratory diag-
nosis of parvovirus, which indicates that they had never met 
parvovirus B19 before. 26.9 % of women had positive indica-
tors of virological and serological markers of virus, they were 
included the main research group, at one time they were subdi-
vided according to gestational periods and symptomatic man-
ifestations of parvovirus infection (1st trimester – 45 women, 
2nd trimester - 48 women). The average gestational period of 
symptomatic manifestation of intrauterine fetal infection was 
19.9±0.5 weeks of gestation. In 33 cases we confirmed the in-
trauterine infection due to parvovirus B19 (testing of placenta 
tissue). The study revealed the distribution of the main group 
of pregnant women according to symptomatic manifestations: 
in the first trimester it was found: 13.3 % of women had as-
ymptomatic course of parvovirus B19 infection during the 
examination; with moderate and severe women symptoms 
during of pregnancy period - 66.6 % and in the presence of 
typical symptoms of the fetus (hydrops, cardiomegaly, fetal 
growth retardation, congenital malformation, calcinosis in the 
liver, spleen, pericardium, severe fetal anemia, etc.) – 20.1 % of 
women. Compared with the 2nd trimester, the asymptomatic 
course of the infection and symptomatic course for the fetus 
had a more pronounced character: asymptomatic – in 39.9 % 
of women compared with the symptomatic maternal course 
during pregnancy – 23 % and severe fetal symptoms were 
identified in – 37.5 % of pregnant women.
Histopathology of the placenta showed a strong interstitial 
and perivascular lymphocytic inflammatory cell infiltrates, 
accompanied by necrosis, fiber breaks and edema. Electron 
microscopy examination of placenta from women with nega-
tive effects for the fetus infected with parvovirus B19 showed 
the presence of small amount of viral particles in the nucleus 
and in the cytoplasm in all studied specimens. To a greater 
extent, determined a cytopathic effect in placental cells due to 
a viral infection that was detected in cells of the cytotropho-
blast, syncytiotrophoblast, endothelial cells, and blood cells. 
It ref lected the state of the cells which infected by the virus 
and was determined as the first stages of autophagy. So, in the 
cytoplasm of these cells, autophagosomes with a double mem-
brane surrounding cell detritus, or virions and their capsids in 
the form of bubbles, were detected. It is known that autopha-
gosomes absorb long-lived proteins, damaged organelles and 
even invasive pathogens. 
It was interested to notice that in fetuses with fetal hydrops 
and poor perinatal outcomes (intrauterine fetal death, stillbirth) 
levels of maternal serum alpha-fetoprotein was significantly 
higher (in 2, 17 times) before detecting the general echographic 
sings of fetal failure (p˂0.05). It appears to be a prognostic mark-
er for poor pregnancy outcome in case of parvovirus B19 infect-
ed pregnancies and should be regularly monitored on the early 
stages of fetal insufficiency. It will be very important to compare 
this indicator with the Doppler blood flow velocity parameters 
in the middle cerebral artery and in the fetal ductus venosus 
with calculation of peripheral vascular resistance indices and to 
predict the possibility of poor perinatal outcomes. 
Parvovirus B19 fractions were visualized in 100 % of cases 
of unauthorized termination of pregnancy with fetal hydrops 
and placental edema in the 12–22 weeks of gestation, while acute 
parvovirus infection in the mother (with the detection of IgM 
against to parvovirus B19) was diagnosed by immunoassay only 
in 62.5 % of cases. 
4. Discussion
19-infected erythroblast cells with intranuclear inclusions 
have been observed in placenta and fetal tissue by many au-
thors with histology and electron microscopy methods [1, 3, 5]. 
In our research the histopathological assessment of placenta 
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in case of parvovirus infection is characterized by pronounced 
placentitis with edema due to the cytolytic action of viruses 
in the core of endothelial cells of the blood capillaries, as well 
as in the cytoplasm, myelin-like structures, which contributes 
to the enhancement of lipid peroxide oxidation. According to 
research data of RF Lamont and co-authors placentitis may 
cause placental dysfunction and adverse fetal outcome [12]. 
The cytopathic effect of infection, which we had established 
in placental cells was determined as the first stages of auto-
phagy, one of the types of death of infected cells. Detection 
of particles of parvovirus B19 in placental tissue of fetuses, 
who suffered from non-immune origin hydrops is an auxiliary 
method in the diagnosis of vertical transmission of parvovirus 
B19 during pregnancy. 
According to recent data of Y. Ling  and co-authors [13] for 
fetal diseases, maternal alpha-fetoprotein is significantly cor-
related with fetal hemoglobin and fetal middle cerebral artery 
blood flow velocity in fetal anemic disease such as red blood cell 
alloimmunisation and parvovirus infection; it was also reported 
that this parameter increases earlier than the increase in MCA 
velocity. Analyzing the received data, we can state that in case of 
parvovirus B19 affected pregnancies its more preferable to esti-
mate the levels of alpha-fetoprotein in maternal serum blood as 
raising levels of this marker may be an early prediction hallmark 
for poor fetal outcome and compare the results of alpha-feto-
protein with the Doppler blood flow velocity parameters in the 
middle cerebral artery, and in the fetal ductus venosus with 
calculation of peripheral vascular resistance indices.
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